✦ LIBER ✦

W1806 Two Years Safety and Efficacy of Tenofovir Disoproxil Fumarate (TDF) in Patients with HBV-Induced Cirrhosis

✍ Scribed by Buti, Maria; Hadziyannis, Stephanos J.; Mathurin, Philippe; Urbanek, Petr; Sherman, Morris; Strasser, Simone I.; Wang, Chia C.; Petersen, Joerg; Heathcote, Jenny; Marcellin, Patrick; Sorbel, Jeff; Mondou, Elsa; Anderson, Jane; Rousseau, Franck

Book ID: 123284964
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 184 KB
Volume: 136
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(09)63992-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

21 TWO YEARS SAFETY AND EFFICACY OF TENO

21 TWO YEARS SAFETY AND EFFICACY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) IN PATIENTS WITH HBV-INDUCED CIRRHOSIS

✍ M. Buti; S. Hadziyannis; P. Mathurin; P. Urbanek; M. Sherman; S. Strasser; C. Wa 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 67 KB

1155 Efficacy of tenofovir disoproxil fu

1155 Efficacy of tenofovir disoproxil fumarate (TDF) for hepatitis B virus (HBV) in human immunodeficiency virus (HIV) infected patients

✍ BENHAMOU, Y; PIKETTY, C; KATLAMA, C; ROZEMBAUM, W; NEAU, D; LAFEUILLADE, A; REY, 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

1028 RENAL SAFETY AND ANTIVIRAL EFFICACY

1028 RENAL SAFETY AND ANTIVIRAL EFFICACY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) MONOTHERAPY IN NUCLEOS(T)IDE ANALOGUE REFRACTORY PATIENTS WITH HEPATITIS B VIRUS (HBV) MONO-INFECTION

✍ van Bömmel, F.; De Man, R.A.; Ferenci, P.; Reijnders, J.G.; Bronowicki, J.-P.; W 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Sa1046 Efficacy of 5 Years of Tenofovir

Sa1046 Efficacy of 5 Years of Tenofovir Disoproxil Fumarate (TDF) in Chronic Hepatitis B Patients With High Viral Load (HBV DNA =9 Log10 Copies/Ml)

✍ Gordon, Stuart C.; Marcellin, Patrick; Krastev, Zahary; Horban, Andrzej; Peterse 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 77 KB

W1814 Safety and Tolerability of 96 Week

W1814 Safety and Tolerability of 96 Weeks of Tenofovir Disoproxil Fumarate (TDF) Treatment in HBeAg Negative and Positive Patients Infected with Chronic Hepatitis B (CHB)

✍ Jacobson, Ira M.; Marcellin, Patrick; Heathcote, Jenny; Mathurin, Philippe; Gane 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 144 KB

544 A EUROPEAN FIELD STUDY OF THE EFFICA

544 A EUROPEAN FIELD STUDY OF THE EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) AS MONOTHERAPY IN PATIENTS WITH PRIOR FAILURE TO OTHER NUCLEOSIDE/NUCLEOTIDE ANALOGUES

✍ F. van Bommel; R. Zoutendijk; R. de Man; J.-P. Bronowiki; K. Rutter; P. Ferenci; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB